Novel Axl-driven signaling pathway and molecular signature characterize high-grade ovarian cancer patients with poor clinical outcome.
about
Guidance of Signaling Activations by Cadherins and Integrins in Epithelial Ovarian Cancer CellsTargeting Stromal-Cancer Cell Crosstalk Networks in Ovarian Cancer TreatmentThe Receptor Tyrosine Kinase AXL in Cancer ProgressionMolecular Pathways: AXL, a Membrane Receptor Mediator of Resistance to TherapyProtein S drives oral squamous cell carcinoma tumorigenicity through regulation of AXL.Axl in ovarian cancer: a step forward for clinical breakthrough?Therapeutic Targeting of AXL Receptor Tyrosine Kinase Inhibits Tumor Growth and Intraperitoneal Metastasis in Ovarian Cancer Models.Axl inhibition induces the antitumor immune response which can be further potentiated by PD-1 blockade in the mouse cancer models.Development of Phosphorothioate DNA and DNA Thioaptamers.Simultaneous E-cadherin and PLEKHA7 expression negatively affects E-cadherin/EGFR mediated ovarian cancer cell growth.
P2860
Q26738643-30269695-3279-4071-BBE9-F3C050E10FDAQ26769963-C35632A3-FE75-46FE-95A9-E0936E72263BQ28068756-D0A93B79-1B3B-4E20-93C1-EA781D12C970Q28070028-D2C3913A-5F55-4985-9A81-71565488CD3FQ41847773-65068F09-5ABE-453E-BCE6-A9282AA7E537Q42316735-264F708F-CAFB-4C81-BBCE-779ED16E064EQ47141265-0BC04B4B-0FCD-42B0-9659-23B42CEE393CQ49737040-611BC793-01C6-4A45-85FE-A13BD61AD0C3Q50893422-777E8B4E-DD19-466C-85E9-739727FEAF9CQ55624634-1A64B38A-5488-4B1B-AB23-68411ED13EB8
P2860
Novel Axl-driven signaling pathway and molecular signature characterize high-grade ovarian cancer patients with poor clinical outcome.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Novel Axl-driven signaling pat ...... ts with poor clinical outcome.
@ast
Novel Axl-driven signaling pat ...... ts with poor clinical outcome.
@en
type
label
Novel Axl-driven signaling pat ...... ts with poor clinical outcome.
@ast
Novel Axl-driven signaling pat ...... ts with poor clinical outcome.
@en
prefLabel
Novel Axl-driven signaling pat ...... ts with poor clinical outcome.
@ast
Novel Axl-driven signaling pat ...... ts with poor clinical outcome.
@en
P2093
P2860
P50
P356
P1433
P1476
Novel Axl-driven signaling pat ...... ts with poor clinical outcome.
@en
P2093
Brigitte Bisaro
Federica Alciato
Floriana Centritto
Francesco Raspagliesi
Gian Carlo Avanzi
Ludmila Lozneanu
Paola Defilippi
Patrizia Pinciroli
Silvana Canevari
P2860
P304
30859-30875
P356
10.18632/ONCOTARGET.5087
P407
P577
2015-09-04T00:00:00Z